Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice

12 Jan 2017

Abstract excerpt

It has been reported that cyclin-dependent kinase 5 (cdk5), a critical neuronal kinase, is hyperactivated in Alzheimer's disease (AD) and may be, in part, responsible for the hallmark pathology of amyloid plaques and neurofibrillary tangles (NFTs). It has been proposed by several laboratories that hyperactive cdk5 results from the overexpression of p25 (a truncated fragment of p35, the normal cdk5 regulator),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Genetics and Neurodevelopmental Disorders
Share to Neuroscience and Neuropharmacology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28085018
DOI: 10.3233/jad-160916

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg MicePMID 28085018Read ↗

A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes.Semantic proximity Read ↗

A cyclin-dependent kinase 5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypesSemantic proximity Read ↗

Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse modelSemantic proximity Read ↗

Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative DiseaseSemantic proximity Read ↗

Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal DementiaSemantic proximity Read ↗

AβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576Semantic proximity Read ↗

Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.Semantic proximity Read ↗

CDK5 activator protein p25 preferentially binds and activates GSK3βSemantic proximity Read ↗

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologySemantic proximity Read ↗

Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.Semantic proximity Read ↗

Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilizationSemantic proximity Read ↗

Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.